CYTOKINE PROFILE OF TH1- AND TH2-DEPENDENT VARIANTS OF CHRONIC GVHD
https://doi.org/10.15789/1563-0625-2012-1-2-67-74
Abstract
Abstract. Induction of chronic GVHD in the DBA/2→(C57Bl/6xDBA/2) F1 semi-allogeneic murine model results into development of Th1- and Th2-dependent immunopathological conditions that are characterized by different cytokine profiles. Chronic GVHD is accompanied by a sharp increase in IgE levels, thus presuming considerable IL-4 production. In recipients with Th2-dependent GvHD variant, elevated contents of serum IL-6, IL-7 and TNFα were also observed, which, along with other effects, may support polyclonal activation of B cells, thus leading to development of autoimmune pathology.
About the Authors
O. T. Kudaeva
НИИ клинической иммунологии СО РАМН, г. Новосибирск
Russian Federation
Russian Federation
V. O. Tkachev
НИИ клинической иммунологии СО РАМН, г. Новосибирск
Russian Federation
Russian Federation
E. D. Gavrilova
НИИ клинической иммунологии СО РАМН, г. Новосибирск
Russian Federation
Russian Federation
E. V. Goiman
НИИ клинической иммунологии СО РАМН, г. Новосибирск
Russian Federation
Russian Federation
N. N. Volsky
НИИ клинической иммунологии СО РАМН, г. Новосибирск
Russian Federation
Russian Federation
O. M. Perminova
НИИ клинической иммунологии СО РАМН, г. Новосибирск
Russian Federation
Russian Federation
O. P. Kolesnikova
НИИ клинической иммунологии СО РАМН, г. Новосибирск
Russian Federation
Russian Federation
References
1. Власов В.В., Рыкова Е.Ю., Сафронова И.В., Лактионов П.П., Кудаева О.Т., Козлов В.А. Модуляция течения хронической реакции трансплантат против хозяина под действием плазмидной ДНК // ДАН. – 2002. – Т. 32. – З.844-846.
2. Гойман Е.В., Кудаева О.Т., Ильина Н.А., Борисов В.И., Кожевников В.С., Колесникова О.П., Козлов В.А. Процессы гомеостатической пролиферации в патогенезе аутоиммунного гломерулонефрита, индуцированного хронической реакцией «трансплантат против хозяина» // Бюл. Эксп. Биол. Мед. – 2010. – № 1. – С. 60-63.
3. Козлов В.А., Кудаева О.Т., Колесникова О.П., Сафронова И.В., Лактионов П.В., Рыкова Е.Ю., Обухова Л.А. Th1- и Th2-зависимые варианты хронической реакции трансплантат против хозяина // Иммунология. – 2002. – № 3. – С. 143-146.
4. Колесникова О.П., Кудаева О.Т., Логинов В.А., Робинсон М.В., Колесникова С.М., Козлов В.А. Показатели эритро- и иммунопоэза в развитии аутоиммунных заболеваний, индуцированных хронической реакцией трансплантат против хозяина // Вестн. АМН СССР. – 1991. – № 12. – С. 13-16.
5. Кудаева О.Т., Ненашева Е.В., Козлов В.А. Определение содержания иммуноглобулинов в цельной крови // Иммунология. – 2005. – № 3. – С. 189-191.
6. Кудаева О.Т., Гойман Е.В., Лыков А.П., Колесникова О.П., Козлов В.А. Влияние препаратов, изменяющих соотношение Th1/Th2, на частоту развития клинических вариантов хронической реакции трансплантат против хозяина // Бюл. Эксп. Биол. Мед. – 2005. – № 9. – С. 325-327.
7. Кудаева О.Т., Гаврилова Е.Д., Гойман Е.В., Ненашева Е.В., Колесникова О.П., Козлов В.А. Особенности иммунодепрессии при хронической реакции «трансплантат против хозяина» // Иммунология. – 2010. – № 4. – С. 199-203.
8. Перминова О.М., Вольский Н.Н., Кудаева О.Т., Гойман Е.В., Козлов В. А. Дислипидемия и Th1/Th2-соотношение на разных этапах развития хронической реакции «трансплантат против хозяина» // Иммунология. – 2009. – № 6. – С. 341-345.
9. Ткачев В.О., Ненашева Е.В., Гойман Е.В., Вольский Н.Н., Кудаева О.Т. Колесникова О.П. Уровень аутоантител к ДНК и метаболическая активность полиморфноядерных лейкоцитов в динамике хронической реакции трансплантат против хозяина // Иммунология. – 2006. – № 2. – С. 98-101.
10. Шевелёв А.С. Реакция «трансплантат против хозяина» и трансплантационная болезнь – М.: Медицина, 1976. – 216 с.
11. Aringer M., Stummvoll G.H., Steiner G., Koller M., Steiner C.W., Hofler E., Hiesberger H., Smolen J.S., Graninger W.B. Serum interleukin-15 is elevated in systemic lupus erythematosus // Rheumatology. – 2001. – Vol. 40. – P. 876-881.
12. Aringer M., Smolen J.S. SLE-complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus // Artritis Res. Ther. – 2003. – Vol. 5. – P. 172-177.
13. Aringer M., Smolen J.S. The role of tumor necrosis factor-alpha in systemic lupus erythematosus // Arthritis Res Ther. – 2008. – Vol. 10. – P. 202-209.
14. Baccala R. & Theofilopoulos A.N. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity // Trends Immunol. – 2005. – Vol. 26. – P. 5-8.
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding // Anal. Biochem. – 1976. – Vol. 72. – P. 248-254.
16. Bulanova E., Budagian V., Duitman E., Orinska Z., Krause H., Ruckert R., Reiling N., Bulfone-Paus S. Soluble interleukin (IL)-15ra is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15 // J. Biological Chem. – 2007. – Vol. 282. – P. 13167-13179.
17. Bunjes D., Theobald M., Nierle T., Arnold R., Heimpel H. Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graftversus host disease // Bone Marrow Transplant. – 1995. – Vol. 15. – P. 727-732.
18. Chu Y.-W., Gress R.E. Murine models of chronic graft-versus-host disease: insights and unresolved issues // Biol. Blood Marrow Transplant. – 2008. – Vol. 14. – P. 365-378.
19. Chun H.Y., Chung J.W., Kim H.A., Yun J.M., Jeon J.Y., Ye Y.M., Kim S.H., Park H.S., Suh C.H. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus // J. Clin. Immunol. – 2007. – Vol. 27. – P. 461-466.
20. Diehl S. & Rincon M. The two faces of IL-6 on Th1/Th2 differentiation // Mol. Immunol. – 2002. – Vol. 39. – P. 531-536.
21. Ferrara J.L.M., Abhyankar S., Gilliland D.G. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1 // Transplant. Proc. – 1993. – Vol. 25. – P. 1216-1217.
22. Ferrara J.L.M. Cytokines and the regulation of tolerance // J. Clin. Invest. – 2000. – Vol. 105. – P. 1043-1044.
23. Garlisi C.G., Pennline K.J., Smith S.R., Siegel M.I., Umland S.P. Cytokine gene expression in mice undergoing chronic graft-versus-host disease // Mol. Immunol. – 1993. – Vol. 30. – P. 669-677.
24. Gleichmann E., Pals S.T., Rolink A.G., Radaszkiewicz T., Gleichmann H. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases // Immunol. Today. – 1984. – Vol. 5. – P. 324-332.
25. Kataoka Y., Iwasaki T., Kuroiwa T. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease // Immunology. – 2001. – Vol. 103. – P. 310-318.
26. Khoruts A., Fraser J.M. A causal link between lymphopenia and autoimmunity // Immunol. Lett. – 2005. – Vol. 98. – P. 23-31.
27. Kimura K., Ida S., Shimada K., Kanai Y. Specificity of anti-nuclear antibodies induced in F1 mice undergoing the graft versus host reaction: isotypes and cross-reactivities // Clin. Exp. Immunol. – 1987. – Vol. 69. – P. 385-393.
28. Kimura M., Gleichmann E. Depressed antibody responses to exogenous antigens in mice with lupus-like graft-versus-host disease // Clin. Immunol. Immunopathol. – 1987. – Vol. 43. – P. 97-109.
29. Koreth J., Antin J.H. Current and future approaches for control of graft-versus-host disease // Expert Rev. Hematol. – 2008. – Vol. 1. – P. 111-141.
30. Krenger W., Ferrara J.L.M. Graft-versushost disease and the Th1/Th2 paradigm // Immunol. Res. – 1996. – Vol. 15. – P. 50-73.
31. Maeda T., Nomoto K. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels // J. Rheumatol. – 1995. – Vol. 22. – P. 2259-2265.
32. Marleau A.M., Sarvetnick N. T-cell homeostasis in tolerance and immunity // J. Leukoc. Biol. – 2005. – Vol. 78. – P. 575-584.
33. Meziere C., Stockl F., Batsford J., Vogt A., Muller S. Antibodies to DNA, chromatin core particles and histones in mice with GvHD and their involvement in glomerular injury // Clin.Exp. Immunol. – 1994. – Vol. 98. – P. 287-294.
34. Mori T., Nishimura T., Ikeda Y., Hotta T., Yagita H., & Ando K. Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graftversus-host reaction-associated myelosuppression // Blood. – 1998. – Vol. 92. – P. 101-107.
35. Morris S.C., Cheek R.L., Cohen P.L., Eisenberg R.A. Autoantibodies in chronic graft versus host result from cognate T-B interactions // J. Exp. Med. – 1990. – Vol. 171. – P. 503-517.
36. Murphy W.J., Welniak L.A., Taub D.D., Wiltrout R.H., Taylor P.A., Vallera D.A., Kopf M., Young H., Longo D.L., Blazar B.R. Differential effects of the absence of interferon-gamma and IL-4 in acute graftversus-host disease after allogeneic bone marrow transplantation in mice // J. Clin. Invest. – 1998. – Vol. 102. – P. 1742-1748.
37. Okamoto I., Kohno K., Tanimoto T., Iwaki K., Ishihara T., Akamatsu S., Ikegami H., Kurimoto M. IL-18 prevents the development of chronic graftversus-host disease in mice // J. Immunol. – 2000. – Vol. 164. – P. 6067-6074.
38. Quinn L.S., Anderson B.G., Strait-Bodey L., Wolden-Hanson T. Serum and muscle interleukin-15 levels decrease in aging mice; correlation with declines in soluble interleukin-15 receptor alpha expression // Exp. Gerontol. – 2010. – Vol. 45. – P. 106-130.
39. Reddy P., Negrin R., Hill G.R. Mouse models of bone marrow transplantation // Biol. Blood Marrow Transplant. – 2008. – Vol. 14. – P. 129-135.
40. Rus V., Svetic A., Nguyen P., Gause W.C., Via C.S. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells // J. Immunol. – 1995. – Vol. 155. – P. 2396-2406.
41. Schorlemmer H.U., Kurrle R., Bartlett R.R. The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodents // Drugs Exp. Clin. Res. – 1997. – Vol. 23. – P. 167-173.
42. Shustov A., Luzina I., Nguyen P., Papadimitriou J. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity // J. Clin. Invest. – 2000. – Vol. 106. – P. R39-R47.
43. Surth C.D., Sprent J. Homeostatic T cell proliferation: how far can T cells be activated to selfligands // Immunity. – 2008. – Vol. 29. – P. 848-862.
44. Umland S.P., Razac S., Nahrebne D.K., Seymour B.W. Effect of in vivo administration of interferon-gamma, anti-IFN-gamma, or anti-IL-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease // Clin. Immunol. Immunopathol. – 1992. – Vol. 63. – P. 66-73.
45. Ushiyama C., Hirano T., Miyajima H., Okumura K., Ovary Z., Hashimoto H. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease // J. Immunol. – 1995. – Vol. 154. – P. 2687-2696.
46. Van Belle T., Grooten J. IL-15 and IL15Ralpha in CD4 T-cell immunity // Arch. Immonol. Ther. Exp. – 2005. – Vol. 53. – P. 115-126.
47. Via C.S., Rus V., Gately M.K., Finkelman F.D. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease // J. Immunol. – 1994. – Vol. 153. – P. 4040-4047.
48. Waldman M., Madaio M.P. Pathogenic autoantibodies in lupus nephritis // Lupus. – 2005. – Vol. 14. – P. 19- 24.
49. Watkins S.K., Li B., Richardson K.S., Head K., Egilmez N.K., Zeng Q., Suttles J., Stout R.D. Rapid release of cytoplasmic IL-1 from tumor associated macrophages is an initial and critical event in IL-12 initiated tumor regression // Eur. J. Immunol. – 2009. – Vol. 39. – P. 2126-2135.
50. Zhu L.J., Landolt-Marticorena C., Li T., Yang X., Yu X.Q., Gladman D.D., Urowitz M.B., Foortin P.R., Wither J.E. Altered expression of TNFalpha signaling pathway proteins in systemic lupus erythematosus // J. Rheumatol. – 2010. – Vol. 37. – P. 1658-1666.
Review
For citations:
Kudaeva O.T., Tkachev V.O., Gavrilova E.D., Goiman E.V., Volsky N.N., Perminova O.M., Kolesnikova O.P. CYTOKINE PROFILE OF TH1- AND TH2-DEPENDENT VARIANTS OF CHRONIC GVHD. Medical Immunology (Russia). 2012;14(1-2):67-74. (In Russ.) https://doi.org/10.15789/1563-0625-2012-1-2-67-74
Views:
3288
Email this article 